trial · primary record
Biological SC-CAR.CLEC2Av1
Acute Myeloid Leukemia
| Phase | Phase 1 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 20 |
| Primary completion | 2043-02 |
| Primary endpoint | Number of participants experiencing Dose Limiting Toxicities (DLTs) and treatment-related adverse events as assessed by NCI CTCAE v6.0, ASTCT CRS/ICANS scales, and IEC-HS grading. |
| Registry ID | NCT07905027 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-29T14:33:56.084Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07905027
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.